Target
Tyrosine-protein kinase TXK
Ligand
BDBM164638
Substrate
n/a
Meas. Tech.
ChEMBL_1983374 (CHEMBL4616780)
IC50
5.0±n/a nM
Citation
 Watterson, SHLiu, QBeaudoin Bertrand, MBatt, DGLi, LPattoli, MASkala, SCheng, LObermeier, MTMoore, RYang, ZVickery, RElzinga, PADiscenza, LD'Arienzo, CGillooly, KMTaylor, TLPulicicchio, CZhang, YHeimrich, EMcIntyre, KWRuan, QWesthouse, RACatlett, IMZheng, NChaudhry, CDai, JGalella, MATebben, AJPokross, MLi, JZhao, RSmith, DRampulla, RAllentoff, AWallace, MAMathur, ASalter-Cid, LMacor, JECarter, PHFura, ABurke, JRTino, JA Discovery of Branebrutinib (BMS-986195): A Strategy for Identifying a Highly Potent and Selective Covalent Inhibitor Providing Rapid in Vivo Inactivation of Bruton's Tyrosine Kinase (BTK). J Med Chem 62:3228-3250 (2019) [PubMed]  Article 
Target
Name:
Tyrosine-protein kinase TXK
Synonyms:
PTK4 | Protein-tyrosine kinase 4 | RLK | Resting lymphocyte kinase | TXK | TXK_HUMAN | Tyrosine-protein kinase TXK (TXK)
Type:
Protein
Mol. Mass.:
61268.80
Organism:
Homo sapiens (Human)
Description:
P42681
Residue:
527
Sequence:
MILSSYNTIQSVFCCCCCCSVQKRQMRTQISLSTDEELPEKYTQRRRPWLSQLSNKKQSNTGRVQPSKRKPLPPLPPSEVAEEKIQVKALYDFLPREPCNLALRRAEEYLILEKYNPHWWKARDRLGNEGLIPSNYVTENKITNLEIYEWYHRNITRNQAEHLLRQESKEGAFIVRDSRHLGSYTISVFMGARRSTEAAIKHYQIKKNDSGQWYVAERHAFQSIPELIWYHQHNAAGLMTRLRYPVGLMGSCLPATAGFSYEKWEIDPSELAFIKEIGSGQFGVVHLGEWRSHIQVAIKAINEGSMSEEDFIEEAKVMMKLSHSKLVQLYGVCIQRKPLYIVTEFMENGCLLNYLRENKGKLRKEMLLSVCQDICEGMEYLERNGYIHRDLAARNCLVSSTCIVKISDFGMTRYVLDDEYVSSFGAKFPIKWSPPEVFLFNKYSSKSDVWSFGVLMWEVFTEGKMPFENKSNLQVVEAISEGFRLYRPHLAPMSIYEVMYSCWHEKPEGRPTFAELLRAVTEIAETW
  
Inhibitor
Name:
BDBM164638
Synonyms:
BDBM166759 | US10604504, Example 223 | US11623921, Example 223 | US9688629, 123 | US9802915, Example 123 | US9920031, Example 223
Type:
Small organic molecule
Emp. Form.:
C20H23FN4O2
Mol. Mass.:
370.4206
SMILES:
CC#CC(=O)N[C@H]1CCCN(C1)c1c(F)cc(C(N)=O)c2[nH]c(C)c(C)c12 |r|
Structure:
Search PDB for entries with ligand similarity: